NAS:ATAI (Germany)  
ATAI Life Sciences NV logo

ATAI Life Sciences NV

$ 3.31 +0.06 (+1.85%) 10:08 PM EST
P/E:
At Loss
P/B:
1.72
Market Cap:
$ 549.05M
Enterprise V:
$ 237.18M
Volume:
524.49K
Avg Vol (2M):
732.85K
Also Trade In:
Volume:
524.49K
Market Cap $:
549.05M
PE Ratio:
At Loss
Avg Vol (2-Month):
732.85K
Enterprise Value $:
237.18M
PB Ratio:
1.72
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
Name Current Vs Industry Vs History
Cash-To-Debt 504.82
Equity-to-Asset 0.89
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 9.44
Distress
Grey
Safe
Beneish M-Score 111.18
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 38.09
9-Day RSI 34.11
14-Day RSI 35.77
6-1 Month Momentum % -11.59
12-1 Month Momentum % -69.57

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 14.74
Quick Ratio 14.74
Cash Ratio 14.23

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-11-15 Est.)

ATAI's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:ATAI

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.666
EPS (TTM) ($) -1.31
Beta 0
Volatility % 54.35
14-Day RSI 35.77
14-Day ATR ($) 0.258205
20-Day SMA ($) 3.781
12-1 Month Momentum % -69.57
52-Week Range ($) 2.95 - 17.81
Shares Outstanding (Mil) 165.88

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ATAI Life Sciences NV Filings

Document Form Filing Date
No Filing Data

ATAI Life Sciences NV Analysis

Share your research

Headlines

See More
No news.